A detailed history of Pingora Partners LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Pingora Partners LLC holds 22,234 shares of BMY stock, worth $1.24 Million. This represents 0.81% of its overall portfolio holdings.

Number of Shares
22,234
Previous 22,234 -0.0%
Holding current value
$1.24 Million
Previous $923 Million 24.58%
% of portfolio
0.81%
Previous 0.65%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$40.25 - $52.99 $32,200 - $42,392
-800 Reduced 3.47%
22,234 $923 Million
Q1 2024

May 13, 2024

BUY
$47.98 - $54.4 $112,752 - $127,840
2,350 Added 11.36%
23,034 $1.25 Billion
Q4 2023

Feb 12, 2024

BUY
$48.48 - $57.85 $1 Million - $1.2 Million
20,684 New
20,684 $1.06 Billion

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $119B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Pingora Partners LLC Portfolio

Follow Pingora Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pingora Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pingora Partners LLC with notifications on news.